Two Sigma Investments
BIOA

Two Sigma Investments’s BioAge Labs BIOA Stock Holding History

Two Sigma Investments’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$821K Buy
46,951
+4,800
+11% +$92.4K ﹤0.01% 3408
2025
Q4 		$558K Sell
42,151
-57,518
-58% -$510K ﹤0.01% 3245
2025
Q3 		$586K Buy
99,669
+35,068
+54% +$164K ﹤0.01% 2909
2025
Q2 		$267K Buy
64,601
+49,456
+327% +$199K ﹤0.01% 2832
2025
Q1 		$56.9K Buy
+15,145
New +$70K ﹤0.01% 3030
2024
Q4 		– Sell
-11,500
Closed -$239K – 3534
2024
Q3 		$239K Buy
+11,500
New +$230K ﹤0.01% 2753

Other funds holding BIOA

ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Two Sigma Investments's BIOA Position: Q1 2026 in Review

Two Sigma Investments increased its BioAge Labs (BIOA) stake by 11% in Q1 2026, buying an estimated $92.4K and bringing the position to 46,951 shares worth $821K. The position accounts for ﹤0.01% of the portfolio, ranked #3408.

Two Sigma Investments first reported a position in BIOA in Q3 2024 and has held it in 6 quarters since. 144 funds tracked by Wall St. Rank hold BIOA as of Q1 2026.

  • Two Sigma Investments held 46,951 shares of BioAge Labs worth $821K as of Q1 2026.
  • Two Sigma Investments bought 4,800 BioAge Labs shares in Q1 2026, an estimated $92.4K.
  • BioAge Labs made up ﹤0.01% of Two Sigma Investments's portfolio in Q1 2026, its #3408 holding.
  • Two Sigma Investments first reported a position in BioAge Labs in Q3 2024 and has held it in 6 quarters since.
  • 144 funds tracked by Wall St. Rank held BioAge Labs as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.